{"count": 13, "results": [{"_id": "33575515", "pmid": 33575515, "pmcid": "PMC7864123", "title": "Perindopril/amlodipine-induced thrombotic microangiopathy", "journal": "Turk J Emerg Med", "authors": ["Periša V", "Laslo D", "Maričić L", "Zibar L"], "date": "2020-12-01T00:00:00Z", "doi": "10.4103/2452-2473.301915", "meta_date_publication": "2021 Jan-Mar", "meta_volume": "21", "meta_issue": "1", "meta_pages": "38-41", "score": 50260.707, "text_hl": "Very seldom @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ may cause @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@hematologic abnormalities@@@, probably through an immunological mechanism, but there were no reports of causing @DISEASE_Thrombotic_Microangiopathies @DISEASE_MESH:D057049 @@@TMA@@@ so far. ", "citations": {"NLM": "Periša V, Laslo D, Maričić L, Zibar L. Perindopril/amlodipine-induced thrombotic microangiopathy Turk J Emerg Med. 2021 Jan-Mar;21(1):38-41. PMID: 33575515", "BibTeX": "@article{33575515, title={Perindopril/amlodipine-induced thrombotic microangiopathy}, author={Periša V and Laslo D and Maričić L and Zibar L}, journal={Turk J Emerg Med}, volume={21}, number={1}, pages={38-41}}"}}, {"_id": "39551851", "pmid": 39551851, "title": "Efficacy and Safety of Yangxue Qingnao Pills Combined with Amlodipine in Treatment of Hypertensive Patients with Blood Deficiency and Gan-Yang Hyperactivity: A Multicenter, Randomized Controlled Trial.", "journal": "Chin J Integr Med", "authors": ["Wang F", "Gao HQ", "Lyu Z", "Wang XM", "Han H", "Wang YX", "Lu F", "Dong B", "Pu J", "Liu F", "Zu XG", "Liu HB", "Yang L", "Zhang SY", "Yan YM", "Wang XL", "Chen JH", "Liu M", "Yang YM", "Li XY"], "date": "2024-11-18T00:00:00Z", "doi": "10.1007/s11655-024-4001-4", "meta_date_publication": "2024 Nov 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.605, "text_hl": "Efficacy and Safety of Yangxue Qingnao Pills Combined with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in Treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@Blood Deficiency@@@ and @DISEASE_Yang_Deficiency @DISEASE_MESH:D016711 @@@Gan-Yang Hyperactivity@@@: A Multicenter, Randomized Controlled Trial.", "citations": {"NLM": "Wang F, Gao HQ, Lyu Z, Wang XM, Han H, Wang YX, Lu F, Dong B, Pu J, Liu F, Zu XG, Liu HB, Yang L, Zhang SY, Yan YM, Wang XL, Chen JH, Liu M, Yang YM, Li XY. Efficacy and Safety of Yangxue Qingnao Pills Combined with Amlodipine in Treatment of Hypertensive Patients with Blood Deficiency and Gan-Yang Hyperactivity: A Multicenter, Randomized Controlled Trial. Chin J Integr Med. 2024 Nov 18;():. PMID: 39551851", "BibTeX": "@article{39551851, title={Efficacy and Safety of Yangxue Qingnao Pills Combined with Amlodipine in Treatment of Hypertensive Patients with Blood Deficiency and Gan-Yang Hyperactivity: A Multicenter, Randomized Controlled Trial.}, author={Wang F and Gao HQ and Lyu Z and Wang XM and Han H and Wang YX and Lu F and Dong B and Pu J and Liu F and Zu XG and Liu HB and Yang L and Zhang SY and Yan YM and Wang XL and Chen JH and Liu M and Yang YM and Li XY}, journal={Chin J Integr Med}}"}}, {"_id": "19673666", "pmid": 19673666, "title": "Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.", "journal": "Expert Rev Cardiovasc Ther", "authors": ["Chrysant SG"], "date": "2009-08-01T00:00:00Z", "doi": "10.1586/erc.09.85", "meta_date_publication": "2009 Aug", "meta_volume": "7", "meta_issue": "8", "meta_pages": "887-95", "score": 50069.58, "text_hl": "In a large, randomized, placebo-controlled study (Combination of @CHEMICAL_Olmesartan_Medoxomil @CHEMICAL_MESH:D000068557 @@@Olmesartan medoxomil@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine besylate@@@ in Controlling High @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure [COACH]) of 1940 @SPECIES_9606 @@@patients@@@, the high-dose combinations of @CHEMICAL_Olmesartan_Medoxomil @CHEMICAL_MESH:D000068557 @@@olmesartan medoxomil@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ 40/10 mg/day reduced the sitting systolic and diastolic @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure by 29/19 mmHg from baseline (p < 0.001) and resulted in 54% of @SPECIES_9606 @@@patients@@@ achieving @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure goals. ", "citations": {"NLM": "Chrysant SG. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension. Expert Rev Cardiovasc Ther. 2009 Aug;7(8):887-95. PMID: 19673666", "BibTeX": "@article{19673666, title={Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.}, author={Chrysant SG}, journal={Expert Rev Cardiovasc Ther}, volume={7}, number={8}, pages={887-95}}"}}, {"_id": "8512761", "pmid": 8512761, "title": "A comparison of amlodipine with enalapril in the treatment of moderate/severe hypertension.", "journal": "Br J Clin Pharmacol", "authors": ["Fowler G", "Webster J", "Lyons D", "Witte K", "Crichton WA", "Jeffers TA", "Wickham EA", "Sanghera SS", "Cornish R", "Petrie JC"], "date": "1993-05-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1993.tb04175.x", "meta_date_publication": "1993 May", "meta_volume": "35", "meta_issue": "5", "meta_pages": "491-8", "score": 50068.047, "text_hl": "Although the reduction in @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure was greater for the @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ treated group, the differences between treatments were not statistically significant. 6. ", "citations": {"NLM": "Fowler G, Webster J, Lyons D, Witte K, Crichton WA, Jeffers TA, Wickham EA, Sanghera SS, Cornish R, Petrie JC. A comparison of amlodipine with enalapril in the treatment of moderate/severe hypertension. Br J Clin Pharmacol. 1993 May;35(5):491-8. PMID: 8512761", "BibTeX": "@article{8512761, title={A comparison of amlodipine with enalapril in the treatment of moderate/severe hypertension.}, author={Fowler G and Webster J and Lyons D and Witte K and Crichton WA and Jeffers TA and Wickham EA and Sanghera SS and Cornish R and Petrie JC}, journal={Br J Clin Pharmacol}, volume={35}, number={5}, pages={491-8}}"}}, {"_id": "8641743", "pmid": 8641743, "title": "A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.", "journal": "Hypertension", "authors": ["Antonios TF", "Cappuccio FP", "Markandu ND", "Sagnella GA", "MacGregor GA"], "date": "1996-06-01T00:00:00Z", "doi": "10.1161/01.hyp.27.6.1325", "meta_date_publication": "1996 Jun", "meta_volume": "27", "meta_issue": "6", "meta_pages": "1325-8", "score": 50064.15, "text_hl": "The results show that in @SPECIES_9606 @@@patients@@@ whose @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressures are not controlled by the combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@, the addition of @CHEMICAL_Bendroflumethiazide @CHEMICAL_MESH:D001539 @@@bendrofluazide@@@ 5 mg once daily causes a significant fall in @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure compared with placebo and a significantly greater fall than 100 mg @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ once daily.", "citations": {"NLM": "Antonios TF, Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA. A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril. Hypertension. 1996 Jun;27(6):1325-8. PMID: 8641743", "BibTeX": "@article{8641743, title={A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.}, author={Antonios TF and Cappuccio FP and Markandu ND and Sagnella GA and MacGregor GA}, journal={Hypertension}, volume={27}, number={6}, pages={1325-8}}"}}, {"_id": "26176708", "pmid": 26176708, "pmcid": "PMC5034748", "title": "Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Rump LC", "Ammentorp B", "Laeis P", "Scholze J"], "date": "2016-01-01T00:00:00Z", "doi": "10.1111/jch.12621", "meta_date_publication": "2016 Jan", "meta_volume": "18", "meta_issue": "1", "meta_pages": "60-9", "score": 50059.926, "text_hl": "Adding @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@Hydrochlorothiazide@@@ to @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@Olmesartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ Increases Efficacy in @SPECIES_9606 @@@Patients@@@ With Inadequate @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@Blood@@@ Pressure Control on Dual-Combination Therapy", "citations": {"NLM": "Rump LC, Ammentorp B, Laeis P, Scholze J. Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy J Clin Hypertens (Greenwich). 2016 Jan;18(1):60-9. PMID: 26176708", "BibTeX": "@article{26176708, title={Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy}, author={Rump LC and Ammentorp B and Laeis P and Scholze J}, journal={J Clin Hypertens (Greenwich)}, volume={18}, number={1}, pages={60-9}}"}}, {"_id": "20407632", "pmid": 20407632, "pmcid": "PMC2856580", "title": "Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update", "journal": "Vasc Health Risk Manag", "authors": ["Destro M", "Cagnoni F", "D'Ospina A", "Ricci AR", "Demichele E", "Peros E", "Zaninelli A", "Preti P"], "date": "2010-04-15T00:00:00Z", "doi": "10.2147/vhrm.s6805", "meta_date_publication": "2010 Apr 15", "meta_volume": "6", "meta_issue": "", "meta_pages": "253-60", "score": 50059.312, "text_hl": "Inclusion of a diuretic in the triple combination is based on the evidence that these agents are effective and cheap, enhance the effect of other antihypertensive agents, and add a specific effect to individuals with salt-sensitivity of @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure. The benefit of triple combination therapy with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ and @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ over its dual component therapies has been demonstrated, and the use of a single pill will simplify therapy resulting in better @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure control.", "citations": {"NLM": "Destro M, Cagnoni F, D'Ospina A, Ricci AR, Demichele E, Peros E, Zaninelli A, Preti P. Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update Vasc Health Risk Manag. 2010 Apr 15;6():253-60. PMID: 20407632", "BibTeX": "@article{20407632, title={Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update}, author={Destro M and Cagnoni F and D'Ospina A and Ricci AR and Demichele E and Peros E and Zaninelli A and Preti P}, journal={Vasc Health Risk Manag}, volume={6}, pages={253-60}}"}}, {"_id": "21804575", "pmid": 21804575, "title": "Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.", "journal": "Acta Pharmacol Sin", "authors": ["Shang W", "Han P", "Yang CB", "Gu XW", "Zhang W", "Xu LP", "Fu ST", "Su DF", "Xie HH"], "date": "2011-09-01T00:00:00Z", "doi": "10.1038/aps.2011.88", "meta_date_publication": "2011 Sep", "meta_volume": "32", "meta_issue": "9", "meta_pages": "1109-15", "score": 50057.625, "text_hl": "AIM: To investigate the synergism of low-doses of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Irbesartan @CHEMICAL_MESH:D000077405 @@@irbesartan@@@ on reduction of @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure variability (BPV), amelioration of baroreflex sensitivity (BRS) and organ protection in spontaneously @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@ (SHR). ", "citations": {"NLM": "Shang W, Han P, Yang CB, Gu XW, Zhang W, Xu LP, Fu ST, Su DF, Xie HH. Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats. Acta Pharmacol Sin. 2011 Sep;32(9):1109-15. PMID: 21804575", "BibTeX": "@article{21804575, title={Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.}, author={Shang W and Han P and Yang CB and Gu XW and Zhang W and Xu LP and Fu ST and Su DF and Xie HH}, journal={Acta Pharmacol Sin}, volume={32}, number={9}, pages={1109-15}}"}}, {"_id": "16700870", "pmid": 16700870, "title": "Selective imidazoline agonist moxonidine in obese hypertensive patients.", "journal": "Int J Clin Pract", "authors": ["Sanjuliani AF", "de Abreu VG", "Francischetti EA"], "date": "2006-05-01T00:00:00Z", "doi": "10.1111/j.1368-5031.2006.00951.x", "meta_date_publication": "2006 May", "meta_volume": "60", "meta_issue": "5", "meta_pages": "621-9", "score": 50056.66, "text_hl": "Our results showed that @CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ significantly reduced @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure when measured using the oscillometric method and 24-hour @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure monitoring. ", "citations": {"NLM": "Sanjuliani AF, de Abreu VG, Francischetti EA. Selective imidazoline agonist moxonidine in obese hypertensive patients. Int J Clin Pract. 2006 May;60(5):621-9. PMID: 16700870", "BibTeX": "@article{16700870, title={Selective imidazoline agonist moxonidine in obese hypertensive patients.}, author={Sanjuliani AF and de Abreu VG and Francischetti EA}, journal={Int J Clin Pract}, volume={60}, number={5}, pages={621-9}}"}}, {"_id": "9327716", "pmid": 9327716, "title": "Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.", "journal": "Am Heart J", "authors": ["Lombardo M", "Alli C", "Broccolino M", "Ferrari S", "Montemurro L", "Zaini G", "Zanni D"], "date": "1997-09-01T00:00:00Z", "doi": "10.1016/s0002-8703(97)70095-4", "meta_date_publication": "1997 Sep", "meta_volume": "134", "meta_issue": "3", "meta_pages": "557-64", "score": 50054.383, "text_hl": "Both drugs significantly reduced @<m>DISEASE_Hematologic_Diseases</m> @DISEASE_MESH:D006402 @@@blood@@@ pressure, casual or monitored (p < 0.01), and left ventricular mass index (from 125 +/- 32 to 100 +/- 12 gm/m2 [p < 0.02] with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and from 106 +/- 18 to 89 +/- 10 gm/m2 [p < 0.02] with @CHEMICAL_Fosinopril @CHEMICAL_MESH:D017328 @@@fosinopril@@@). ", "citations": {"NLM": "Lombardo M, Alli C, Broccolino M, Ferrari S, Montemurro L, Zaini G, Zanni D. Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension. Am Heart J. 1997 Sep;134(3):557-64. PMID: 9327716", "BibTeX": "@article{9327716, title={Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.}, author={Lombardo M and Alli C and Broccolino M and Ferrari S and Montemurro L and Zaini G and Zanni D}, journal={Am Heart J}, volume={134}, number={3}, pages={557-64}}"}}]}